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A B S T R A C T
Ageing is associated with the development of a low-level, systemic, chronic inflammation known as “in-
flammaging”. This chronic inflammatory state can contribute to diseases of ageing such as sarcopenia and frailty.
The presence of inflammaging suggests a failure of the cell clearance mechanisms that ordinarily aid in the
resolution of inflammation after pathogen infiltration or tissue injury. This review aims to explore what is known
of how the processes involved in the resolution of inflammation might become defective with age.
1. Introduction
Acute inflammation is the set of processes that constitute the body’s
initial response to tissue injury that might be associated with an in-
vading pathogen. Sterile and non-sterile tissue injury both result in
acute inflammation, and the cellular responses that are triggered are
geared towards limiting microbial infection and repairing damaged
tissues.
Inflammation is characterised by infiltration of the injured or in-
vaded site by extravasated neutrophils. Following extravasation, neu-
trophils and other inflammatory cells can undergo forms of pro-
grammed cell death that render them liable to be phagocytosed by
macrophages in order to restore tissue homeostasis as inflammation
resolves (Fig. 1). This particular form of phagocytosis by macrophages –
termed “efferocytosis” – provides a safe means to dispose of apoptotic
neutrophils that would otherwise progress to a state of secondary ne-
crosis during which histotoxic neutrophil contents could leak into the
local environment and cause tissue damage (Rydell-Törmänen et al.,
2006). Efferocytosis also appears to polarise macrophages to a pattern
of behaviour that acts to limit the recruitment of further neutrophils as
a pathogen is cleared, promoting the resolution of inflammation and
restoring tissue homeostasis (Huynh et al., 2002).
It is recognised that with age the mechanisms regulating in-
flammation become impaired in a manner that might contribute to a
susceptibility of older people to infection and age-related chronic dis-
eases (Pawelec et al., 2014). This dysregulation has been inferred in
part from an observation of increased circulating pro-inflammatory
cytokines and acute phase proteins in older people even in the absence
of infection, suggesting a low-level chronic inflammation of ageing
known as “inflammaging” (Bartlett et al., 2012; Ferrucci et al., 2005;
Pinti et al., 2014). The inappropriate persistence of inflammation with
age has been postulated to result in tissue damage which results in
further inflammation and more tissue damage, leading to the “cycle of
inflammaging” and predisposing to age-related diseases such as ather-
osclerosis and dementia (Baylis et al., 2013).
The development of a persistent age-related inflammation may
suggest the development of defects in the processes relating to the re-
solution of inflammation including efferocytosis. This review explores
the roles of efferocytosis and associated signalling in the resolution of
inflammation, aiming to assess the existing evidence regarding changes
in these processes with ageing.
2. The effect of ageing on apoptosis, efferocytosis and macrophage
polarisation
2.1. The effect of ageing on neutrophil apoptosis
As inflammation resolves, scavenger cells such as macrophages in
tissues attempt to clear superfluous neutrophils that have extravasated
to respond to an insult. In experiments involving the co-culture of
monocyte-derived macrophages with isolated neutrophils, Savill and
colleagues demonstrated that the proportion of neutrophils ingested by
the macrophages was directly linked to the proportion of neutrophils
that were apoptotic (Savill et al., 1989). It was therefore concluded that
apoptosis acts as a flag by which macrophages preferentially recognise
redundant neutrophils for clearance, suggesting that the process of
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apoptosis plays a central role in the resolution of inflammation.
During apoptosis, cells undergo morphological changes that result
in condensed nuclei, closely packed organelles and lucent cytoplasmic
vacuoles (Kerr et al., 1972). Another crucial structural change in
apoptotic cells is the oxidation and relocation of the membrane lipid
phosphatidylserine, which moves from the inner plasma membrane
leaflet to the outer plasma membrane leaflet. The increased outward
exposure of oxidised phosphatidylserine by apoptotic cells is one of the
best-described signals by which macrophages recognise them for en-
gulfment in preference to non-apoptotic cells (Fadok et al., 1992;
Greenberg et al., 2006).
Ageing does not appear to affect the rate at which unstimulated
neutrophils undergo spontaneous apoptosis in culture (Fülöp Jr et al.,
1997), although this tells us little about how the cells will behave in
conditions of inflammation. When attending inflamed environments
after extravasation, it is often the case that neutrophils are exposed to
signals to delay apoptosis (Luo and Loison, 2008). Ageing seems to
reduce the responsiveness of neutrophils to these anti-apoptotic signals,
which include granulocyte-macrophage colony stimulating factor (GM-
CSF), lipopolysaccharide (LPS) and IL-2. In experiments using isolated
neutrophils from the venous blood of healthy younger (aged 20–25)
and older human volunteers (aged 65–85), Fülöp et al. found that al-
though GM-CSF, LPS and IL-2 delayed apoptosis in neutrophils from
both sets of volunteers, the anti-apoptotic effects of these compounds
on the neutrophils from the older volunteers were weaker (Fülöp Jr
et al., 1997).
Neutrophils will also be subject to pro-apoptotic stimuli that are
present in inflamed environments, but initiation of apoptosis in this
way, at least via the Fas receptor on the cell surface that can trigger the
extrinsic apoptotic pathway, appears unaffected by age. Tortorella et al.
identified similar neutrophil surface expression of Fas in neutrophils
from younger (aged 22–32) and older (aged over 65) human volunteers,
and ligation of the Fas receptor by monoclonal anti-Fas IgM resulted in
similar rates of apoptosis in both sets of neutrophils. Much like in the
Fülöp study, however, Tortorella and colleagues observed a reduced
sensitivity of Fas-ligated neutrophils to anti-apoptotic factors such as
GM-CSF and LPS with age (Tortorella et al., 1998).
There are scant data on the impact of ageing on phosphatidylserine
externalisation during apoptosis. Espino and colleagues provide some
useful results within a study investigating the modulatory effect of
melatonin on leukocyte apoptosis. The findings suggest that neutrophils
isolated from the peripheral blood of healthy older human volunteers
(aged 65–75) externalised greater amounts of phosphatidylserine than
neutrophils from healthy younger volunteers (aged 20–30) when sti-
mulated to undergo apoptosis in vitro with the endoplasmic reticulum
stressor thapsigargin or the ROS-inducing formyl peptide fMLP (Espino
et al., 2011). The results must be accepted with caution as the ex-
ternalisation of phosphatidylserine was quantified using a fluorophore-
conjugated annexin V binding assay, and some authors have expressed
reservations about the sensitivity of fluorometric assays for the assess-
ment of absolute numbers of externalised phosphatidylserine molecules
rather than the less precise assessment of the loss of membrane lipid
asymmetry (Fabisiak et al., 2014; Morita et al., 2011).
2.2. The effect of ageing on tissue macrophage chemotaxis
For efferocytosis to take place it is often necessary for macrophages
to migrate towards regions of an inflammatory milieu containing
greater numbers of apoptotic cells. To promote this, apoptotic cells
release chemotactic mediators that serve to draw macrophages towards
them. Lauber et al. found that culture supernatants of varieties of cells
irradiated to induce apoptosis were able to stimulate migration of
Fig. 1. Macrophage efferocytosis. An apoptotic neutrophil at an inflamed site is recognised by a macrophage and phagocytosed. The interaction of the macrophage
with the apoptotic cell results in macrophage secretion of pro-resolution cytokines and downregulation of pro-inflammatory cytokines. If efferocytosis is impaired (as
in ageing), the apoptotic neutrophil may progress to secondary necrosis, allowing leakage of histotoxic contents, resulting in tissue injury, further pro-inflammatory
signalling and chronic inflammation. Image created with BioRender.com.
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macrophages and monocytes. Further testing established one of the
chemotactic factors to be the phospholipid lysophosphatidylcholine
(LPC), which was released by the apoptotic cells after initiation of
apoptosis (Lauber et al., 2003).
As well as lipid chemoattractants such as LPC and sphingosine-1-
phosphate, apoptotic cells can secrete nucleotides that attract scavenger
cells. The nucleotides ATP and UDP, found in greater concentrations in
the supernatants of apoptotic primary thymocytes and Jurkat T cells by
Elliott et al., were shown to have monocyte chemoattractant ability in
vitro and in vivo through their interactions with P2Y purinergic re-
ceptors on monocytic cells (Elliott et al., 2009).
The effect of ageing on macrophage chemotaxis is poorly in-
vestigated, especially where human macrophages are concerned. It
might be tempting to draw conclusions about macrophage chemotaxis
from studies of circulating monocyte function, but there is compelling
evidence that resident tissue macrophages are of distinct lineage to
circulating monocytes. Using mouse models, Hashimoto et al. were able
to show that circulating monocytes contributed minimally to popula-
tions of tissue macrophages in steady state, even during repopulation
after cytoablation (Hashimoto et al., 2013). This is probably not the
case during inflammation, however. Peripheral blood monocytes have
been observed to enter the human lung during experimental in-
flammation and subsequently adopt gene expression profiles that sug-
gest an ability to regulate the immune response in a similar manner to
alveolar macrophages (Jardine et al., 2019). It is not known how long
these monocyte-macrophages stay in the tissues after infiltration and
whether (and if so, to what extent) they play a role in the clearance of
apoptotic cells.
In any case, there is little evidence to suggest peripheral monocyte
chemotactic ability is impaired with age. Two studies have suggested no
effect of age on general chemotaxis, although in addition to the caveat
regarding the use of monocytes as a model for macrophages, it is worth
noting that the monocytes were not tested for chemotaxis towards
chemoattractants typically released from apoptotic cells as described
above (Gardner et al., 1981; Nielsen et al., 1984).
Primary macrophages have been employed to investigate tissue
macrophage chemotaxis in ageing but studies show varying results.
Forner et al. observed an age-related decline in chemotaxis towards
casein in peritoneal macrophages from mice and guinea pigs (Forner
et al., 1994). Wustrow et al. noted increasing chemotactic capability
with age in peritoneal macrophages from C57BL/6 mice (Wustrow
et al., 1982). The chemoattractant in the latter study was serum in-
cubated with a Salmonella species to activate complement protein C5.
Given that it is possible to impair chemotaxis specifically towards
chemoattractants known to be secreted by apoptotic cells and leave
general chemotaxis intact (Yang et al., 2005), evidence regarding age-
related change in macrophage movement towards efferocytosis-asso-
ciated chemotactic factors in particular would be welcomed.
2.3. The effect of ageing on macrophage recognition and phagocytosis of
apoptotic cells
Although by no means an exclusive flag for macrophage engulf-
ment, oxidised phosphatidylserine on the apoptotic cell surface can
engage with a macrophage to stimulate phagocytosis in a variety of
ways (Fig. 2). Some macrophage membrane receptors such as BAI1 and
TIM4 have been shown to engage directly with phosphatidylserine, but
engagement can also occur via bridging molecules such as milk fat
globule-epidermal growth factor-factor VIII (MFG-E8), which serves as
a link between phosphatidylserine and prophagocytic αvβ3 or αvβ5
integrins on the macrophage surface (Miksa et al., 2007; Poon et al.,
2014). Thrombospondin 1 (TSP1) is another bridging molecule that has
been shown to tether phosphatidylserine on the surfaces of apoptotic
neutrophils to macrophages by binding CD36 and αvβ3 integrin co-
operatively on the macrophage surface (Savill et al., 1992). Calreticulin
acts in a similar manner after being secreted by macrophages,
decorating the surfaces of apoptotic neutrophils to allow engagement
by the macrophage prophagocytic receptor CD91. In contrast to MFG-
E8 and TSP1, calreticulin adheres to asialoglycans on the target cells
rather than externalised phosphatidylserine (Feng et al., 2018).
Despite a lack of interrogation of the mechanisms, it does appear
that macrophage phagocytosis of apoptotic cells is diminished with age.
In a mouse model, in vivo peritoneal macrophages in aged (24-month-
old) mice showed impaired efferocytosis of intraperitoneally injected
apoptotic Jurkat cells compared to younger (2-month-old) mice
(Aprahamian et al., 2008). A similar observation was made by Arnar-
dottir et al. using in vitro mouse bone marrow derived macrophages in
culture with apoptotic neutrophils isolated from human peripheral
blood. Again, the macrophages from aged (20-month-old) mice were
less efficient at clearing the neutrophils than macrophages from 2-
month-old mice. It was postulated that this contributed to an overall
impairment of the resolution of inflammation with increasing age
(Arnardottir et al., 2014).
It is unknown whether this defect is mediated by an impaired re-
cognition of apoptotic cells by macrophages, for instance as a con-
sequence of attenuated expression of phosphatidylserine receptors such
as TIM4 or reduced production of phosphatidylserine opsonins such as
MFG-E8. MFG-E8 knockout mice display features of autoimmunity in a
similar pattern to systemic lupus erythematosus, developing elevated
serum antinuclear antibodies and glomerulonephritis secondary to
renal immunoglobulin deposition (Hanayama et al., 2004). It is sug-
gested that this might be due to impaired efferocytosis of apoptotic B
cells or perhaps the impaired maturation of mononuclear cell phago-
somes; poor efferosome maturation could result in aberrant cross pre-
sentation of apoptotic cell-derived self antigens to T cells (Hanayama
et al., 2004; Peng and Elkon, 2011). Although this autoimmune syn-
drome is not quite consistent with typical observations of age-related
chronic neutrophilic inflammation, it is worth noting that some authors
have proposed an association between ageing and autoimmunity given
that elevated serum antinuclear antibodies can be demonstrated in
older, healthy human populations (Andersen-Ranberg et al., 2004;
Manoussakis et al., 1987).
By contrast, TIM4 knockout mice display a phenotype that is char-
acterised by an increased cellularity of the peritoneum in homeostasis
with elevated concentrations of the pro-inflammatory cytokine TNF-α
in peritoneal lavage fluid (Wong et al., 2010). It is probably more en-
ticing to draw parallels between this phenotype and that observed in
the ageing human lung, in which increased cellularity and IL-8 con-
centrations in BAL fluid can be found at steady state (Meyer et al.,
1998).
2.4. The effect of ageing on macrophage polarisation
It is possible that the features of inflammaging arise due to a failure
of macrophages to polarise to a phenotype that favours the resolution of
inflammation. A pro-resolution pattern of macrophage behaviour (en-
hanced efferocytosis, enhanced secretion of anti-inflammatory and pro-
resolution cytokines) is often referred to as alternative macrophage
activation or M2 activation. It is important to note that while the
commonly used nomenclature of “M1″ and “M2″ activation implies a
linear spectrum or dichotomy of pro- or anti-inflammatory polarisation,
a more accurate model is probably that of multidimensional polarisa-
tion in response to variations in the macrophage microenvironment
(Byrne et al., 2016).
The mechanisms that govern the change in macrophage behaviour
at the time of efferocytosis are not fully understood. The interaction
between phosphatidylserine on the outer surface of an apoptotic cell
and direct or indirect phosphatidylserine receptors on the macrophage
surface does appear to play a role, however, and the alteration in sig-
nalling profile looks to take place even prior to target engulfment or
internalisation. When actin polymerisation is inhibited with cytocha-
lasin D to limit macrophage engulfment of prey, contact between
W. Sendama Ageing Research Reviews 57 (2020) 101000
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apoptotic cells and macrophages is still enough to produce a diminution
of NF-κB-dependent transcription of genes coding for pro-inflammatory
cytokines (Cvetanovic and Ucker, 2004).
It is not clear to what extent the polarisation of macrophages by the
efferocytosis of apoptotic material shares the mechanisms of polarisa-
tion as a result of other stimuli such as IL-4, IL-10, corticosteroids or
specialised pro-resolving mediators. If the mechanisms are similar, then
there is potentially relevant evidence that ageing might impair polar-
isation. In a study comparing mice aged 18–20 months to younger mice
aged 10–12 weeks, splenic macrophages from the older mice showed
less pronounced mRNA expression of M2-associated genes such as Arg1,
FIZZ1 and Ym1 compared to macrophages from the younger mice when
pre-stimulated with IL-4 (Mahbub et al., 2012). Bone marrow-derived
macrophages differentiated ex vivo did not display the same age-asso-
ciated impairment of polarisation, leading the researchers to conclude
that the defect might arise due to an alteration of the tissue micro-
environment with ageing rather than some intrinsic change in macro-
phage function.
2.4.1. Ageing and specialised pro-resolving mediators
Macrophages can be polarised to a pro-resolution phenotype by
specialised pro-resolving mediators (SPMs), a superfamily of bioactive
substances biosynthesised from essential fatty acids. SPMs include the
lipoxins, resolvins, protectins and maresins, which serve to resolve in-
flammation actively by mechanisms that include enhanced macrophage
efferocytosis and the inhibition of further neutrophil extravasation
(Serhan, 2014).
In a model employing intraperitoneal zymosan challenge to induce
a spontaneously-resolving peritonitis in mice, Arnadottir and colleagues
found that an observed delay in resolution of inflammation in older (20
month old) mice compared to younger (2 month old) mice was asso-
ciated with lower levels of SPMs in peritoneal lavage fluid (Arnardottir
et al., 2014). Human monocytes reprogrammed by incubation with
SPMs took on a phenotype similar to M2 macrophages and were able to
promote resolution when injected into inflamed mouse peritoneal
cavities, although the question of whether age affected the extent to
which human monocytes could be reprogrammed was not in the scope
of the study.
It is possible that ageing impairs the biosynthesis of SPMs. Halade
et al. reported similar levels of arachidonic acid-derived eicosanoids
(including lipoxin B4) in the spleens of young (6 months) and aged 18
months) mice up until the induction of myocardial infarction by cor-
onary artery ligation, at which point splenic levels of eicosanoids de-
creased to a greater extent in aged mice than young mice. Ageing was
associated with reduced mRNA expression of lipoxygenase enzymes,
which are essential in the derivation of eicosanoids from arachidonic
acid (Halade et al., 2016). The conclusion that ageing might impair
production of pro-resolution eicosanoids is shared by Gangemi and
colleagues, who found that ageing was associated with reduced urinary
lipoxin A4 in healthy human volunteers (Gangemi et al., 2005).
3. Discussion
The onset of inflammaging suggests a combination of inappropriate
initiation of inflammation and inadequate resolution of inflammation
with age. The potential contributors to inappropriate pro-inflammatory
responses in ageing have been described in detail elsewhere (Franceschi
and Campisi, 2014; Singh and Newman, 2011) but the factors that
might contribute to defects in the resolution of inflammation are per-
haps less well documented.
Mononuclear phagocytes in tissues play an important role in the
resolution of inflammation by clearing apoptotic material at inflamed
sites and undertaking pro-resolution signalling. Some of the evidence
reviewed above from animal models would suggest that the ability of
Fig. 2. Macrophage recognition of phosphati-
dylserine on the apoptotic cell surface.
Abbreviations: TIM4, T-cell membrane protein
4; BAI1, brain-specific angiogenesis inhibitor
1; MFG-E8, milk fat globule-epidermal growth
factor 8; TSP1, thrombospondin 1; oxPS, oxi-
dised phosphatidylserine. Image created with
BioRender.com.
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macrophages to recognise and clear apoptotic cells is impaired with
age, but if these findings are to lead to therapies to combat inflamma-
ging there is a need for such experiments to be carried out using human
models of ageing. Such studies might also consider whether tissue-re-
sident macrophages and monocyte-derived macrophages play distinct
roles in the resolution of inflammation.
Although cells other than professional phagocytes have been noted
to undertake efferocytosis (Juncadella et al., 2013; Lee et al., 2016), the
recognition of macrophages as the foremost effectors of efferocytosis
means that it is possible to target therapies to these cells to enhance
efferocytosis. 3-hydroxyl-3-methylglutaryl coenzyme A reductase in-
hibitors (statins) have shown promise in this regard. Lovastatin has
been shown to enhance efferocytosis in alveolar macrophages obtained
from patients with chronic obstructive pulmonary disease (Morimoto
et al., 2006), a condition that is often characterised by chronic lung
inflammation. Wootton and colleagues were able to demonstrate en-
hanced efferocytosis by macrophages from patients taking statins as
they recovered from pneumonia (Wootton et al., 2016). Studies speci-
fically designed to investigate inflammaging are required to discern
whether such therapies targeted at efferocytosis can blunt the chronic
inflammation of ageing and limit the impact of associated tissue da-
mage.
Specialised pro-resolving mediators appear promising in the bid to
reverse age-related deficiencies in the resolution of inflammation. As
reviewed above, human monocytes reprogrammed by such lipid med-
iators can enhance resolution of experimental inflammation in the
mouse peritoneal cavity (Arnardottir et al., 2014), but it is not yet
known whether these substances can be fashioned into drugs that re-
liably attenuate age-related inflammation in humans. The association of
dysregulation of these mediators with the development of age-related
diseases such as Alzheimer’s disease (Wang et al., 2015) and athero-
sclerosis (Laguna-Fernandez et al., 2018) suggests that the pathways
could be exploited for patient benefit, but again, further translational
studies are required if SPM-modulating therapies to enhance the re-
solution of inflammaging are to be developed.
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